Grace Therapeutics Inc - GRCE Total Stockholders' Equity
Grace Therapeutics, Inc. (GRCE) maintains a high reputation for developing advanced therapies for rare brain pathologies. The company implements AI modeling and robotics to accelerate drug discovery and minimize manual analysis. A key metric has been recorded at the 0.06 level, and this daily price chart complements data regarding the staff of top-tier scientists united by a common scientific goal.
%20Company%20Book%20Value&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_GRCE_-_Grace-Therapeutics-Inc._-_Company-Book-Value "GRCE Grace Tx Accounting Capitalization (10/29/2024 - 10/29/2026) | 👁️GURU.Markets👁️")
GRCE (Grace Tx): analytical breakdowns and indicator data
- market value and analyst target forecast:
- issuer market value details:
- company book value details:
- debt and liquidity data:
Total Debt to Capital Grace Therapeutics, Inc.|GRCE - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Grace Therapeutics, Inc.|GRCE - Company Debts|Debts to Book Value Grace Therapeutics Inc|GRCE - Company Long-Term Debts|Short-Term Indebtedness Grace Therapeutics|Intermediate Coverage Ratio gracetx.com
- earnings and valuation multiples information:
Initial company analysis:GRCE, Grace Therapeutics
Amid growing demand for innovative treatments for rare neurological pain, Grace Therapeutics, Inc. (GRCE) requires significant capital expenditures in drug delivery infrastructure. Monitoring balance sheet capitalization allows for an assessment of the company's actual net asset volume minus all liabilities, determining the business's intrinsic value. The position of quotes relative to this line indicates whether there is a margin of safety or a risk of capital overvaluation.
Competitor analysis for Grace Therapeutics, Inc.
Biogen Idec (BIIB) - Company Net Assets|NBIX: Book Capitalization|Total Stockholders' Equity regencellbioscience.com (RGC)|Company Book Value Axsome Therapeutics, Inc.|Accounting Capitalization ACAD (ACADIA Pharma)|Book Capitalization XENE|VKTX - Total Stockholders' Equity|Supernus Pharmaceuticals - Company Net Assets|Book Capitalization catalystpharma.com CPRX|DNLI - Company Book Value|Accounting Value of Company HRMY (Harmony Biosciences Inc)|Biohaven Pharmaceutical (BHVN) - Company Book Value|Total Stockholders' Equity Amylyx Corp (AMLX)|TRVI (Trevi Therapeutics) - Book Capitalization|PRAX - Book Value of Business|Company Book Value Anavex Life Sciences Corp. (AVXL)|CBLL (CeriBell Inc) - Accounting Value of Company|Book Capitalization PRTA (prothena.com)|Book Capitalization Alector Inc. ALEC|Annexon, Inc. - Book Capitalization|Omeros Corporation (OMER) - Company Net Assets|NGNE: Book Capitalization|Total Stockholders' Equity AC Immune S.A. (ACIU)|Company Net Assets VYGR|NMRA: Accounting Value of Company|Company Net Assets SCLX (Scilex Holding Company)|Total Net Assets TVGN|Book Capitalization ACOG (Alpha Cognition Inc.)|Accounting Value of Company CGTX|Inhibikase - Book Capitalization|Total Stockholders' Equity Cassava Pharma|assertiotx.com (ASRT) - Company Book Value|Coya Therapeutics - Accounting Value of Company|VTGN (VistaGen Therapeutics, Inc.) - Book Capitalization|Book Capitalization Ovid Rx|Company Book Value Acumen Pharma (ABOS)|CRVO: Net Asset Value|Book Capitalization ATHE (Alterity Therapeutics Limited)|Clene Inc (CLNN) - Total Stockholders' Equity|PEPG: Company Net Assets|JUNS - Book Capitalization|RLMD (Relmada) - Company Net Assets|ANVS: Total Net Assets|AIFF (Firefly Neuroscience, Inc) - Book Capitalization|ANEW Medical, Inc. (KLTO) - Book Valuation of Business|Book Capitalization NRSN|Company Net Assets Reviva Pharmaceuticals Holdings Inc. RVPH|Company Book Value MetaVia MTVA|Book Valuation of Business NeurAxis Inc (NRXS)|HSDT: Company Net Assets|Accounting Value of Company PASG (Passage Bio, Inc.)|NEUP: Book Capitalization|NERV - Book Valuation of Business|Company Book Value Athira|Accounting Capitalization ADXN (Addex)|Book Capitalization ALZN|Company Net Assets cyclerion.com CYCN|Protagenic Therapeutics, Inc. - Company Net Assets|Book Valuation of Business Pasithea Therapeutics Corp (KTTA)|Cortigent Medical - Book Capitalization|Book Value of Business Avenue Therapeutics Inc (ATXI)|Brainstorm Cell (BCLI) - Company Book Value|caratherapeutics.com - Accounting Value of Company|CHRO (Chromocell Therapeutics Corp.) - Book Capitalization|Company Net Assets Eliem (ELYM)|Book Capitalization ITCI|LBPH - Total Stockholders' Equity|Company Book Value Marinus Pharmaceuticals MRNS|NKGN: Accounting Capitalization|NeuroBo Pharmaceuticals, Inc. - Book Capitalization|Total Stockholders' Equity Sage Therapeutics Inc.|SNPX (Neurotrope) - Company Net Assets|Trevena Inc (TRVN) - Book Capitalization|Company Book Value Vigil Neuroscience Inc.|WENA: Accounting Value of Company|Company Book Value Cerevel Therapeutics, Inc. (CERE)